Click for best price
Kidney Disease Drugs Market Size, Share 2023
The global Kidney Disease Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Kidney Disease Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Kidney Disease Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Kidney Disease Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Kidney Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Disease Drugs.
This report contains market size and forecasts of Kidney Disease Drugs in global, including the following market information:
- Global Kidney Disease Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global Kidney Disease Drugs Market Sales, 2018-2023, 2024-2030, (K Units)
- Global top five Kidney Disease Drugs companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Kidney Disease Drugs include GlaxoSmithKline, Sanofi, Roche, Pfizer, AstraZeneca, Keryx Biopharmaceuticals, Kissei Pharmaceutical, AbbVie and Amgen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Kidney Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Kidney Disease Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Kidney Disease Drugs Market Segment Percentages, by Type, 2022 (%)
Global Kidney Disease Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Kidney Disease Drugs Market Segment Percentages, by Application, 2022 (%)
- Chronic Glomerulonephritis
- Nephrotic Syndrome
- Chronic Renal Failure
- Kidney Stones
- Renal Cyst (polycystic Kidney)
- Diabetic Nephropathy
- Hypertensive Nephropathy
- Purpura Nephritis
- Lupus Nephritis
- Pediatric Kidney Disease
Global Kidney Disease Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Kidney Disease Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Kidney Disease Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Kidney Disease Drugs revenues share in global market, 2022 (%)
- Key companies Kidney Disease Drugs sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Kidney Disease Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GlaxoSmithKline
- Sanofi
- Roche
- Pfizer
- AstraZeneca
- Keryx Biopharmaceuticals
- Kissei Pharmaceutical
- AbbVie
- Amgen
- Teva Pharmaceutical Industries
- Tianjin Tongrentang Group
- Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
- Datong Liqun Pharmaceutical
- Hebei Ruisen Pharmaceutical
- Changxing Pharmaceutical
- zhejiang Shengbokang Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Kidney Disease Drugs, market overview.
Chapter 2: Global Kidney Disease Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Kidney Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Kidney Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Kidney Disease Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Kidney Disease Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
113 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Kidney Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Kidney Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Kidney Disease Drugs Overall Market Size
2.1 Global Kidney Disease Drugs Market Size: 2022 VS 2030
2.2 Global Kidney Disease Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Kidney Disease Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Kidney Disease Drugs Players in Global Market
3.2 Top Global Kidney Disease Drugs Companies Ranked by Revenue
3.3 Global Kidney Disease Drugs Revenue by Companies
3.4 Global Kidney Disease Drugs Sales by Companies
3.5 Global Kidney Disease Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Kidney Disease Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Kidney Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Kidney Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Kidney Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Kidney Disease Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Kidney Disease Drugs Market Size Markets, 2022 & 2030
4.1.2 Tablets
4.1.3 Capsule
4.1.4 Other
4.2 By Type - Global Kidney Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Kidney Disease Drugs Revenue, 2018-2023
4.2.2 By Type - Global Kidney Disease Drugs Revenue, 2024-2030
4.2.3 By Type - Global Kidney Disease Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Kidney Disease Drugs Sales & Forecasts
4.3.1 By Type - Global Kidney Disease Drugs Sales, 2018-2023
4.3.2 By Type - Global Kidney Disease Drugs Sales, 2024-2030
4.3.3 By Type - Global Kidney Disease Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Kidney Disease Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Kidney Disease Drugs Market Size, 2022 & 2030
5.1.2 Chronic Glomerulonephritis
5.1.3 Nephrotic Syndrome
5.1.4 Chronic Renal Failure
5.1.5 Kidney Stones
5.1.6 Renal Cyst (polycystic Kidney)
5.1.7 Diabetic Nephropathy
5.1.8 Hypertensive Nephropathy
5.1.9 Purpura Nephritis
5.1.10 Lupus Nephritis
5.1.11 Pediatric Kidney Disease
5.2 By Application - Global Kidney Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Kidney Disease Drugs Revenue, 2018-2023
5.2.2 By Application - Global Kidney Disease Drugs Revenue, 2024-2030
5.2.3 By Application - Global Kidney Disease Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Kidney Disease Drugs Sales & Forecasts
5.3.1 By Application - Global Kidney Disease Drugs Sales, 2018-2023
5.3.2 By Application - Global Kidney Disease Drugs Sales, 2024-2030
5.3.3 By Application - Global Kidney Disease Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Kidney Disease Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Kidney Disease Drugs Market Size, 2022 & 2030
6.2 By Region - Global Kidney Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Kidney Disease Drugs Revenue, 2018-2023
6.2.2 By Region - Global Kidney Disease Drugs Revenue, 2024-2030
6.2.3 By Region - Global Kidney Disease Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Kidney Disease Drugs Sales & Forecasts
6.3.1 By Region - Global Kidney Disease Drugs Sales, 2018-2023
6.3.2 By Region - Global Kidney Disease Drugs Sales, 2024-2030
6.3.3 By Region - Global Kidney Disease Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Kidney Disease Drugs Revenue, 2018-2030
6.4.2 By Country - North America Kidney Disease Drugs Sales, 2018-2030
6.4.3 US Kidney Disease Drugs Market Size, 2018-2030
6.4.4 Canada Kidney Disease Drugs Market Size, 2018-2030
6.4.5 Mexico Kidney Disease Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Kidney Disease Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Kidney Disease Drugs Sales, 2018-2030
6.5.3 Germany Kidney Disease Drugs Market Size, 2018-2030
6.5.4 France Kidney Disease Drugs Market Size, 2018-2030
6.5.5 U.K. Kidney Disease Drugs Market Size, 2018-2030
6.5.6 Italy Kidney Disease Drugs Market Size, 2018-2030
6.5.7 Russia Kidney Disease Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Kidney Disease Drugs Market Size, 2018-2030
6.5.9 Benelux Kidney Disease Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Kidney Disease Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Kidney Disease Drugs Sales, 2018-2030
6.6.3 China Kidney Disease Drugs Market Size, 2018-2030
6.6.4 Japan Kidney Disease Drugs Market Size, 2018-2030
6.6.5 South Korea Kidney Disease Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Kidney Disease Drugs Market Size, 2018-2030
6.6.7 India Kidney Disease Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Kidney Disease Drugs Revenue, 2018-2030
6.7.2 By Country - South America Kidney Disease Drugs Sales, 2018-2030
6.7.3 Brazil Kidney Disease Drugs Market Size, 2018-2030
6.7.4 Argentina Kidney Disease Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Kidney Disease Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Kidney Disease Drugs Sales, 2018-2030
6.8.3 Turkey Kidney Disease Drugs Market Size, 2018-2030
6.8.4 Israel Kidney Disease Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Kidney Disease Drugs Market Size, 2018-2030
6.8.6 UAE Kidney Disease Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Kidney Disease Drugs Major Product Offerings
7.1.4 GlaxoSmithKline Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Kidney Disease Drugs Major Product Offerings
7.2.4 Sanofi Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Kidney Disease Drugs Major Product Offerings
7.3.4 Roche Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Kidney Disease Drugs Major Product Offerings
7.4.4 Pfizer Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Kidney Disease Drugs Major Product Offerings
7.5.4 AstraZeneca Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Keryx Biopharmaceuticals
7.6.1 Keryx Biopharmaceuticals Company Summary
7.6.2 Keryx Biopharmaceuticals Business Overview
7.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Major Product Offerings
7.6.4 Keryx Biopharmaceuticals Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Keryx Biopharmaceuticals Key News & Latest Developments
7.7 Kissei Pharmaceutical
7.7.1 Kissei Pharmaceutical Company Summary
7.7.2 Kissei Pharmaceutical Business Overview
7.7.3 Kissei Pharmaceutical Kidney Disease Drugs Major Product Offerings
7.7.4 Kissei Pharmaceutical Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Kissei Pharmaceutical Key News & Latest Developments
7.8 AbbVie
7.8.1 AbbVie Company Summary
7.8.2 AbbVie Business Overview
7.8.3 AbbVie Kidney Disease Drugs Major Product Offerings
7.8.4 AbbVie Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.8.5 AbbVie Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Kidney Disease Drugs Major Product Offerings
7.9.4 Amgen Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Amgen Key News & Latest Developments
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Company Summary
7.10.2 Teva Pharmaceutical Industries Business Overview
7.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.11 Tianjin Tongrentang Group
7.11.1 Tianjin Tongrentang Group Company Summary
7.11.2 Tianjin Tongrentang Group Kidney Disease Drugs Business Overview
7.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Major Product Offerings
7.11.4 Tianjin Tongrentang Group Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Tianjin Tongrentang Group Key News & Latest Developments
7.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
7.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Summary
7.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Business Overview
7.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Major Product Offerings
7.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Key News & Latest Developments
7.13 Datong Liqun Pharmaceutical
7.13.1 Datong Liqun Pharmaceutical Company Summary
7.13.2 Datong Liqun Pharmaceutical Kidney Disease Drugs Business Overview
7.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Major Product Offerings
7.13.4 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Datong Liqun Pharmaceutical Key News & Latest Developments
7.14 Hebei Ruisen Pharmaceutical
7.14.1 Hebei Ruisen Pharmaceutical Company Summary
7.14.2 Hebei Ruisen Pharmaceutical Business Overview
7.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Major Product Offerings
7.14.4 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Hebei Ruisen Pharmaceutical Key News & Latest Developments
7.15 Changxing Pharmaceutical
7.15.1 Changxing Pharmaceutical Company Summary
7.15.2 Changxing Pharmaceutical Business Overview
7.15.3 Changxing Pharmaceutical Kidney Disease Drugs Major Product Offerings
7.15.4 Changxing Pharmaceutical Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Changxing Pharmaceutical Key News & Latest Developments
7.16 zhejiang Shengbokang Pharmaceutical
7.16.1 zhejiang Shengbokang Pharmaceutical Company Summary
7.16.2 zhejiang Shengbokang Pharmaceutical Business Overview
7.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Major Product Offerings
7.16.4 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales and Revenue in Global (2018-2023)
7.16.5 zhejiang Shengbokang Pharmaceutical Key News & Latest Developments
8 Global Kidney Disease Drugs Production Capacity, Analysis
8.1 Global Kidney Disease Drugs Production Capacity, 2018-2030
8.2 Kidney Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Kidney Disease Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Kidney Disease Drugs Supply Chain Analysis
10.1 Kidney Disease Drugs Industry Value Chain
10.2 Kidney Disease Drugs Upstream Market
10.3 Kidney Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Kidney Disease Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Kidney Disease Drugs in Global Market
Table 2. Top Kidney Disease Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Kidney Disease Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Kidney Disease Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Kidney Disease Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Kidney Disease Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Kidney Disease Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Kidney Disease Drugs Product Type
Table 9. List of Global Tier 1 Kidney Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Kidney Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Kidney Disease Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Kidney Disease Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Kidney Disease Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Kidney Disease Drugs Sales (K Units), 2024-2030
Table 16. By Application ? Global Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Kidney Disease Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Kidney Disease Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Kidney Disease Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Kidney Disease Drugs Sales (K Units), 2024-2030
Table 21. By Region ? Global Kidney Disease Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Kidney Disease Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Kidney Disease Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Kidney Disease Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Kidney Disease Drugs Sales (K Units), 2024-2030
Table 26. By Country - North America Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Kidney Disease Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Kidney Disease Drugs Sales, (K Units), 2024-2030
Table 30. By Country - Europe Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Kidney Disease Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Kidney Disease Drugs Sales, (K Units), 2024-2030
Table 34. By Region - Asia Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Kidney Disease Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Kidney Disease Drugs Sales, (K Units), 2024-2030
Table 38. By Country - South America Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Kidney Disease Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Kidney Disease Drugs Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Kidney Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Kidney Disease Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Kidney Disease Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Kidney Disease Drugs Sales, (K Units), 2024-2030
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Kidney Disease Drugs Product Offerings
Table 48. GlaxoSmithKline Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Kidney Disease Drugs Product Offerings
Table 52. Sanofi Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Kidney Disease Drugs Product Offerings
Table 56. Roche Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Kidney Disease Drugs Product Offerings
Table 60. Pfizer Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. AstraZeneca Company Summary
Table 63. AstraZeneca Kidney Disease Drugs Product Offerings
Table 64. AstraZeneca Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. AstraZeneca Key News & Latest Developments
Table 66. Keryx Biopharmaceuticals Company Summary
Table 67. Keryx Biopharmaceuticals Kidney Disease Drugs Product Offerings
Table 68. Keryx Biopharmaceuticals Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Keryx Biopharmaceuticals Key News & Latest Developments
Table 70. Kissei Pharmaceutical Company Summary
Table 71. Kissei Pharmaceutical Kidney Disease Drugs Product Offerings
Table 72. Kissei Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Kissei Pharmaceutical Key News & Latest Developments
Table 74. AbbVie Company Summary
Table 75. AbbVie Kidney Disease Drugs Product Offerings
Table 76. AbbVie Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. AbbVie Key News & Latest Developments
Table 78. Amgen Company Summary
Table 79. Amgen Kidney Disease Drugs Product Offerings
Table 80. Amgen Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Amgen Key News & Latest Developments
Table 82. Teva Pharmaceutical Industries Company Summary
Table 83. Teva Pharmaceutical Industries Kidney Disease Drugs Product Offerings
Table 84. Teva Pharmaceutical Industries Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Teva Pharmaceutical Industries Key News & Latest Developments
Table 86. Tianjin Tongrentang Group Company Summary
Table 87. Tianjin Tongrentang Group Kidney Disease Drugs Product Offerings
Table 88. Tianjin Tongrentang Group Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Tianjin Tongrentang Group Key News & Latest Developments
Table 90. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Summary
Table 91. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product Offerings
Table 92. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Key News & Latest Developments
Table 94. Datong Liqun Pharmaceutical Company Summary
Table 95. Datong Liqun Pharmaceutical Kidney Disease Drugs Product Offerings
Table 96. Datong Liqun Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Datong Liqun Pharmaceutical Key News & Latest Developments
Table 98. Hebei Ruisen Pharmaceutical Company Summary
Table 99. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product Offerings
Table 100. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Hebei Ruisen Pharmaceutical Key News & Latest Developments
Table 102. Changxing Pharmaceutical Company Summary
Table 103. Changxing Pharmaceutical Kidney Disease Drugs Product Offerings
Table 104. Changxing Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Changxing Pharmaceutical Key News & Latest Developments
Table 106. zhejiang Shengbokang Pharmaceutical Company Summary
Table 107. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product Offerings
Table 108. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. zhejiang Shengbokang Pharmaceutical Key News & Latest Developments
Table 110. Kidney Disease Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 111. Global Kidney Disease Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Kidney Disease Drugs Production by Region, 2018-2023 (K Units)
Table 113. Global Kidney Disease Drugs Production by Region, 2024-2030 (K Units)
Table 114. Kidney Disease Drugs Market Opportunities & Trends in Global Market
Table 115. Kidney Disease Drugs Market Drivers in Global Market
Table 116. Kidney Disease Drugs Market Restraints in Global Market
Table 117. Kidney Disease Drugs Raw Materials
Table 118. Kidney Disease Drugs Raw Materials Suppliers in Global Market
Table 119. Typical Kidney Disease Drugs Downstream
Table 120. Kidney Disease Drugs Downstream Clients in Global Market
Table 121. Kidney Disease Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Kidney Disease Drugs Segment by Type in 2022
Figure 2. Kidney Disease Drugs Segment by Application in 2022
Figure 3. Global Kidney Disease Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Kidney Disease Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Kidney Disease Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Kidney Disease Drugs Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Kidney Disease Drugs Revenue in 2022
Figure 9. By Type - Global Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Kidney Disease Drugs Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Kidney Disease Drugs Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Kidney Disease Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Kidney Disease Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 23. US Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 28. Germany Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 37. China Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Kidney Disease Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Kidney Disease Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Kidney Disease Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Kidney Disease Drugs Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Kidney Disease Drugs by Region, 2022 VS 2030
Figure 54. Kidney Disease Drugs Industry Value Chain
Figure 55. Marketing Channels
